Craig-Hallum analyst Matt Hewitt raised the firm’s price target on Champions Oncology (CSBR) to $12 from $8 and keeps a Buy rating on the ...

ALX Oncology (ALXO) will highlight progress across its clinical pipeline, including continued advancement of investigational CD47-blocker evorpacept and planned entry into the clinic of its novel ...

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore.

We analysed new anticancer drug indications approved by the FDA and EMA between 2020 and 2023 using the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale quality-of-life ...

Once they’ve graduated, their education and training include: Medical school Residency in internal medicine Fellowship in hematology oncology (3 years) After completing a medical residency and a ...

Cancer immunotherapy is a therapy used to treat cancer patients that involves or uses components of the immune system. Some cancer immunotherapies consist of antibodies that bind to, and inhibit ...

Choose from Oncology Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Choose from Chemo Icon stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

As of 2:12:27 PM EDT. Market Open. Loading Chart for ALXO ...

After hours: March 13 at 7:59:57 PM EDT Loading Chart for ICON ...

Given different scientific and clinical meeting schedules, considering advances in genitourinary oncology in novel therapies is relevant. AS MANY INITIATIVES are launched at the beginning of the new ...

Julie Gralow, MD, chief medical officer at the American Society of Clinical Oncology (ASCO), recently shed light on the factors contributing to this crisis and what can be done to address it. Gralow ...